We systematically reviewed randomized clinical trials of problem-solving therapy (PST) in older adults. Our results indicate that PST led to greater reduction in depressive symptoms of late-life major depression than supportive therapy (ST) and reminiscence therapy. PST resulted in reductions in depression comparable with those of paroxetine and placebo in patients with minor depression and dysthymia, although paroxetine led to greater reductions than placebo. In home health care, PST was more effective than usual care in reducing symptoms of depression in undiagnosed patients. PST reduced disability more than ST in patients with major depression and executive dysfunction. Preliminary data suggest that a home-delivered adaptation of PST that includes environmental adaptations and caregiver involvement is efficacious in reducing disability in depressed patients with advanced cognitive impairment or early dementia. In patients with macular degeneration, PST led to improvement in vision-related disability comparable to that of ST, but PST led to greater improvement in measures of visionrelated quality of life. Among stroke patients, PST participants were less likely to develop a major or minor depressive episode than those receiving placebo treatment, although the results were not sustained in a more conservative statistical analysis. Among patients with macular degeneration, PST participants had significantly lower 2-month incidence rates of major depression than usual care participants and were less likely to suffer persistent depression at 6 months. Finally, among stroke patients, PST participants were less likely to develop apathy than those receiving placebo treatment. PST also has been delivered via phone, Internet, and videophone, and there is evidence of feasibility and acceptability. Further, preliminary data indicate that PST delivered through the Internet resulted in a reduction in depression comparable with that of in-person PST in home-care patients. PST delivered via videophone results in an improvement in hospice caregivers' quality of life and a reduction in anxiety comparable to those of in-person PST. PST-treated patients with cognitive impairment may require additional compensatory strategies, such as written notes, memory devices, environmental adaptations, and caregiver involvement.
Introduction
Late-life depression worsens the outcomes of medical illnesses, promotes disability, increases expense, and complicates care by clouding the clinical picture and undermining treatment adherence, yet responds only modestly to pharmacotherapy [1] . Problem-solving therapy (PST) is a psychotherapy that has been used widely in psychiatry. Meta-analyses have highlighted the use of PST in a variety of conditions, including depressive disorders, conduct disorders, obesity, and substance abuse, across different populations (including children and young and older adults) and settings (including outpatient, home care, and primary care), and with different outcomes (including mental and physical health and quality of life) [2, 3] .
PST has two premises: 1) Finding the best possible solution to current everyday problems may reduce the experience of stress and improve peoples' lives, and 2) teaching people problem-solving skills will help them solve future problems. Because older adults experience many stressors in everyday life as a result of medical illnesses, losses, disability, and cognitive impairment, a hands-on approach using discrete and easily taught steps to solve problems is appealing and practical. PST includes the following steps: problem orientation, problem definition, generation of solutions (brainstorming), evaluations of solutions, selection of the best possible solution, and solution implementation and evaluation [4, 5] . PST adaptations have been created for different groups of older adults (e.g., PST-ED for depressed patients with executive dysfunction and PATH for homebound depressed patients with advanced cognitive impairment) and settings (PST-PC [PST for primary care] and PST-HC [PST for home health care]).
In the past 5 years, an increasing number of articles utilizing PST for older adults has been reported (Table 1) . Our systematic review focuses on randomized clinical trials (RCTs) of PST in older adults, because RCTs are the state of the art for evidence-based practice and can provide class I and II levels of evidence. PST treatment studies focus on reducing depression and improving functioning and quality of life, whereas PST prevention studies concentrate on delaying the onset of major or minor depression.
Finally, ongoing clinical trials, not included in the current review, focus on using PST or adaptations of PST to a) reduce depression in low-income, homebound [6] , medically ill older adults [7, 8] and opiate abusers [9] ; or b) prevent the onset of depressive episodes in high-risk elders [10] .
Methods
We searched PubMed (1966 PubMed ( -2013 , PsycNET (1840 PsycNET ( -2013 , and Cochrane databases, emphasizing studies from the past 5 years. The searches were conducted using the following keywords: "problem solving therapy," "PST," "old*," and "eld*" (the asterisk denotes any combination of the word). In addition, we selected appropriate studies from previously published metaanalyses and reviews. Inclusion criteria of studies were a) an RCT using problem-solving therapy [4, 5] , b) published in English, and c) with the average participant 60 years old or older. This review does not include interventions that included PST as only one aspect or step of the treatment (e.g., Improving Mood-Promoting Access to Collaborative Treatment [IMPACT], Program to Encourage Active, Rewarding Lives [PEARL], or other stepped-cared programs), because PST was given in combination with other depression interventions and the relative effect of PST could not be determined. We identified 734 abstracts and potential articles through our searches, 15 of which were original RCTs that met our criteria; of those, 12 were published in the past 5 years (see Table 1 for the characteristics of the 15 RCTs). Two of 15 were prevention studies in patients with macular degeneration and stroke. The following treatment options are based mainly on results from the analyses of primary outcomes. • Depressed older adults with advanced cognitive impairment: Participants in home-delivered PATH had a significantly greater reduction in depression than participants in home-delivered ST. Cohen's d was 0.77, but it also must be interpreted with caution considering the small sample size (N=30) [14] .
• Participants in group PST show a greater reduction in depression at 3 months (post treatment) than participants in group RT and those in the wait-list control condition. Estimated Cohen's d between PST vs. RT was 1.08.
Minor depression, dysthymia, or depression symptoms
The results are based on three studies of PST-PC [16• class I study] in minor depression or dysthymia and PST-HC [17, 18] in depression in home-care patients. Compared with usual care, PST had a greater reduction in depression in home-care patients; however, compared with paroxetine or placebo, PST had a reduction in depression similar to that of paroxetine and placebo in patients with dysthymia and minor depression.
Standard procedure • PST-PC: Six sessions in 11 weeks delivered by doctoral-level psychologists, social workers, and counselors with master's degrees.
• PST-HC: Six sessions in 6 [18] or 8 weeks [17] delivered by master's-level social workers. Special points • PST-PC participants had a reduction in depression comparable to that of participants in the placebo or paroxetine group among patients with dysthymia or minor depression.
• Among home-care patients with subthreshold depression and cardiovascular disease, participants in PST-HC had a significantly greater reduction in depression than usual-care participants.
• Among home-care patients with significant depressive symptoms, participants in PST-HC had a greater reduction in depression and greater improvement in quality of life over the course of 6 months than usual-care participants.
Prevention of depression and apathy
The results are based on two studies of prevention in patients with macular degeneration ( [19•] and [20] used the same sample) and stroke patients ( [21•] and [22] used data from the same clinical trial). In one study, the outcome was prevention of a major depressive episode [19• class I study, 20] , whereas in the other, the outcome was prevention of a major or minor episode of depression [21• class I study] or prevention of onset of apathy [22] . Stroke patients participating in PST were less likely to develop a major or minor depressive episode than those in the placebo group. This difference became nonsignificant in a more conservative analysis, which assumed that baseline patients who did not continue the study would have developed depression. Among patients with macular degeneration, PST participants had significantly lower 2-month incidence rates of major depression than usual-care participants and were less likely to suffer persistent depression at 6 months. In a recent analysis of the study sample of Robinson et al. [21•] of the subjects who did not exhibit apathy at baseline, escitalopram or PST was significantly more effective in preventing new onset of apathy following stroke compared with placebo [22] . • Stroke study [22] (outcome: onset of apathy): placebo participants were 3.47 times more likely than escitalopram patients and 1.84 times more likely than PST patients to develop apathy.
Functioning, frailty, and quality of life
Disability
The results are based on three studies of PST [12, 14, 15] . Two multisite studies [12, 15] used PST-ED; the other study used PATH for depressed patients with advanced cognitive impairment including dementia [14] . All studies used depression treatment as a control condition (ST) [12, 14, 15] . PST participants had significantly greater reduction in disability at 12 weeks than ST participants in all three studies. In one study [15] , the benefits of PST vs. ST were sustained between 12 and 36 weeks.
Standard procedure • PST-ED [12, 15] : 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
• Home-delivered PATH (problem adaptation therapy) [14] : 12 sessions in 12 weeks delivered by a doctoral-level clinical psychologist and licensed social worker. Special points Exploratory analyses revealed that disability mediated the effects of depression at the end of treatment (12 weeks).
Targeted vision function
The results are based on only one study of patients with age-related macular degeneration [23] . PST participants did not have greater improvement in vision function than ST participants in the primary outcome measure at 3 months (end of treatment) or 6 months but had greater improvement in the secondary outcome of vision-related quality of life [23] .
Standard procedure • Six sessions in 12 weeks delivered by therapists with a bachelor's or master's degree. Special points • PST targeting functional problems of vision loss and reducing the difficulty of vision-dependent tasks did not show significant improvement over ST at 3 and 6 months after baseline [23] .
• PST showed greater improvement in the secondary outcome of vision-related quality of life compared with ST.
Frailty
The results are based on only one study of frail community older adults [24] . Participants receiving PST did not have significant improvement in any of the frailty measures: weight loss, exhaustion, low activity level, slowness, and weakness.
Standard procedure • Six sessions in 3 months delivered by trained case managers.
Quality of life
The results are based on one study [25] focusing on a group of outpatients who screened positive for psychological problems by the Chinese version of the Hospital Anxiety and Depression Scale. PST-PC participants had improvement in health-related quality of life comparable with that of placebo participants who watched health education videos.
Standard procedure • PST-PC: three sessions in 6 weeks delivered by primary care doctors. Special points Although participants in PST-PC had significant improvement in the roleemotional and mental components of the SF-36 Health-Related Quality of Life assessment at week 6, whereas the placebo group did not, a mixed-effects analysis accounting for potential covariates and baseline measures did not show any difference between the two groups in any outcome.
Alternative deliveries
& Older adults who are homebound or live in rural areas may need alternative ways to deliver PST, such as phone, videophone, or Internet.
& Special considerations are required for patients with hearing and vision problems as well as patients with cognitive impairment.
Tele-PST
The results are based on three studies of PST delivered through telephone [26] , videophone [27] , or Skype [28] . The subjects for each study were cancer patients [26] , hospice caregivers [27] , and homecare patients with depression [28] .
Standard procedure • Telephone: varied number of sessions (based on negotiation with the patient) in 3 months delivered by nurse counselors.
• Videophone: three sessions in 20 days.
• Skype : six weekly sessions.
Special Points • Delivering PST through phone, videophone, and Internet is feasible and acceptable to vulnerable older adults.
• PST counseling delivered over the phone to cancer patients showed greater improvement in certain coping areas than usual care, but there were no significant differences in reduction of depression or improvement in psychosocial adjustment.
• Videophone-delivered PST showed improvement in caregiver quality of life and reduction in anxiety compared with in-person PST.
• PST delivered through Skype demonstrated results comparable with those of in-person PST in homebound older adults, and both PST conditions showed a greater reduction in depression compared with a condition of support calls [28] . Among patients in the sample, 67 % had major depressive disorder, 29 % had minor depression, and 4 % had dysthymia.
Considerations
Length of treatment & Ten of 15 studies had between 6 and 12 PST sessions in 12 weeks. & The two prevention studies had six sessions in 8 or 12 weeks, and one of them [21•, 22] had six additional sessions in the following 9 months.
Therapists and treatment fidelity
& Therapists included those with a bachelor's or master's degree in social science, master's-level social workers, nurse counselors, advanced graduate students in clinical psychology, and doctoral-level clinical psychologists. & Reviews of recorded sessions and notes were performed in 9 of 15 studies.
Race, education, and socioeconomic status & The majority of participants in most studies were older Caucasian adults with at least 12 years of education. Two studies were con-ducted in Hong Kong [25] and in Taiwan [24] . Future research needs to focus on racially diverse participants, as well as those with limited education and low socioeconomic status.
Cognitive impairment and dementia
& Older adults with cognitive impairment may need compensatory strategies, including written session notes, memory devices, environmental adaptations, and caregiver participation, to help them with their cognitive deficits.
